Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Abatacept in ANCA Associated Vasculitis (ABAVAS)

This study has been terminated.
(Funders withdrew funding due to slow recruitment)
Bristol-Myers Squibb
Information provided by (Responsible Party):
Imperial College London Identifier:
First received: June 1, 2007
Last updated: May 28, 2015
Last verified: March 2015
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Study Completion Date: November 2008
  Primary Completion Date: November 2008 (Final data collection date for primary outcome measure)